Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts

Mingxin Tang, Jie Li, Wei Huang, Huabo Su, Qiangrong Liang, Zongwen Tian, Kathleen M. Horak, Jeffery D. Molkentin, Xuejun Wang

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

AimsProteasome functional insufficiency (PFI) may play an important role in the progression of congestive heart failure but the underlying molecular mechanism is poorly understood. Calcineurin and nuclear factor of activated T-cells (NFAT) are degraded by the proteasome, and the calcineurin-NFAT pathway mediates cardiac remodelling. The present study examined the hypothesis that PFI activates the calcineurin-NFAT pathway and promotes maladaptive remodelling of the heart.Methods and resultsUsing a reporter gene assay, we found that pharmacological inhibition of 20S proteasomes stimulated NFAT transactivation in both mouse hearts and cultured adult mouse cardiomyocytes. Proteasome inhibition stimulated NFAT nuclear translocation in a calcineurin-dependent manner and led to a maladaptive cell shape change in cultured neonatal rat ventricular myocytes. Proteasome inhibition facilitated left ventricular dilatation and functional decompensation and increased fatality in mice with aortic constriction while causing cardiac hypertrophy in the sham surgery group. It was further revealed that both calcineurin protein levels and NFAT transactivation were markedly increased in the mouse hearts with desmin-related cardiomyopathy and severe PFI. Expression of an aggregation-prone mutant desmin also directly increased calcineurin protein levels in cultured cardiomyocytes.ConclusionsThe calcineurin-NFAT pathway in the heart can be activated by proteasome inhibition and is activated in the heart of a mouse model of desmin-related cardiomyopathy that is characterized by severe PFI. The interplay between PFI and the calcineurin-NFAT pathway may contribute to the pathological remodelling of cardiomyocytes characteristic of congestive heart failure.

Original languageEnglish (US)
Pages (from-to)424-433
Number of pages10
JournalCardiovascular Research
Volume88
Issue number3
DOIs
StatePublished - Dec 1 2010
Externally publishedYes

Fingerprint

NFATC Transcription Factors
Calcineurin
Proteasome Endopeptidase Complex
Cardiac Myocytes
Desmin
Cardiomyopathies
Transcriptional Activation
Heart Failure
Cell Shape
Cardiomegaly
Reporter Genes
Constriction
Muscle Cells
Dilatation
Proteins
Pharmacology

Keywords

  • Calcineurin
  • Cardiac remodelling
  • Desmin-related cardiomyopathy
  • Nuclear factors of activated T-cells
  • Proteasome

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. / Tang, Mingxin; Li, Jie; Huang, Wei; Su, Huabo; Liang, Qiangrong; Tian, Zongwen; Horak, Kathleen M.; Molkentin, Jeffery D.; Wang, Xuejun.

In: Cardiovascular Research, Vol. 88, No. 3, 01.12.2010, p. 424-433.

Research output: Contribution to journalArticle

Tang, Mingxin ; Li, Jie ; Huang, Wei ; Su, Huabo ; Liang, Qiangrong ; Tian, Zongwen ; Horak, Kathleen M. ; Molkentin, Jeffery D. ; Wang, Xuejun. / Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. In: Cardiovascular Research. 2010 ; Vol. 88, No. 3. pp. 424-433.
@article{329659549a8b4e52bfeb3c290b139a56,
title = "Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts",
abstract = "AimsProteasome functional insufficiency (PFI) may play an important role in the progression of congestive heart failure but the underlying molecular mechanism is poorly understood. Calcineurin and nuclear factor of activated T-cells (NFAT) are degraded by the proteasome, and the calcineurin-NFAT pathway mediates cardiac remodelling. The present study examined the hypothesis that PFI activates the calcineurin-NFAT pathway and promotes maladaptive remodelling of the heart.Methods and resultsUsing a reporter gene assay, we found that pharmacological inhibition of 20S proteasomes stimulated NFAT transactivation in both mouse hearts and cultured adult mouse cardiomyocytes. Proteasome inhibition stimulated NFAT nuclear translocation in a calcineurin-dependent manner and led to a maladaptive cell shape change in cultured neonatal rat ventricular myocytes. Proteasome inhibition facilitated left ventricular dilatation and functional decompensation and increased fatality in mice with aortic constriction while causing cardiac hypertrophy in the sham surgery group. It was further revealed that both calcineurin protein levels and NFAT transactivation were markedly increased in the mouse hearts with desmin-related cardiomyopathy and severe PFI. Expression of an aggregation-prone mutant desmin also directly increased calcineurin protein levels in cultured cardiomyocytes.ConclusionsThe calcineurin-NFAT pathway in the heart can be activated by proteasome inhibition and is activated in the heart of a mouse model of desmin-related cardiomyopathy that is characterized by severe PFI. The interplay between PFI and the calcineurin-NFAT pathway may contribute to the pathological remodelling of cardiomyocytes characteristic of congestive heart failure.",
keywords = "Calcineurin, Cardiac remodelling, Desmin-related cardiomyopathy, Nuclear factors of activated T-cells, Proteasome",
author = "Mingxin Tang and Jie Li and Wei Huang and Huabo Su and Qiangrong Liang and Zongwen Tian and Horak, {Kathleen M.} and Molkentin, {Jeffery D.} and Xuejun Wang",
year = "2010",
month = "12",
day = "1",
doi = "10.1093/cvr/cvq217",
language = "English (US)",
volume = "88",
pages = "424--433",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts

AU - Tang, Mingxin

AU - Li, Jie

AU - Huang, Wei

AU - Su, Huabo

AU - Liang, Qiangrong

AU - Tian, Zongwen

AU - Horak, Kathleen M.

AU - Molkentin, Jeffery D.

AU - Wang, Xuejun

PY - 2010/12/1

Y1 - 2010/12/1

N2 - AimsProteasome functional insufficiency (PFI) may play an important role in the progression of congestive heart failure but the underlying molecular mechanism is poorly understood. Calcineurin and nuclear factor of activated T-cells (NFAT) are degraded by the proteasome, and the calcineurin-NFAT pathway mediates cardiac remodelling. The present study examined the hypothesis that PFI activates the calcineurin-NFAT pathway and promotes maladaptive remodelling of the heart.Methods and resultsUsing a reporter gene assay, we found that pharmacological inhibition of 20S proteasomes stimulated NFAT transactivation in both mouse hearts and cultured adult mouse cardiomyocytes. Proteasome inhibition stimulated NFAT nuclear translocation in a calcineurin-dependent manner and led to a maladaptive cell shape change in cultured neonatal rat ventricular myocytes. Proteasome inhibition facilitated left ventricular dilatation and functional decompensation and increased fatality in mice with aortic constriction while causing cardiac hypertrophy in the sham surgery group. It was further revealed that both calcineurin protein levels and NFAT transactivation were markedly increased in the mouse hearts with desmin-related cardiomyopathy and severe PFI. Expression of an aggregation-prone mutant desmin also directly increased calcineurin protein levels in cultured cardiomyocytes.ConclusionsThe calcineurin-NFAT pathway in the heart can be activated by proteasome inhibition and is activated in the heart of a mouse model of desmin-related cardiomyopathy that is characterized by severe PFI. The interplay between PFI and the calcineurin-NFAT pathway may contribute to the pathological remodelling of cardiomyocytes characteristic of congestive heart failure.

AB - AimsProteasome functional insufficiency (PFI) may play an important role in the progression of congestive heart failure but the underlying molecular mechanism is poorly understood. Calcineurin and nuclear factor of activated T-cells (NFAT) are degraded by the proteasome, and the calcineurin-NFAT pathway mediates cardiac remodelling. The present study examined the hypothesis that PFI activates the calcineurin-NFAT pathway and promotes maladaptive remodelling of the heart.Methods and resultsUsing a reporter gene assay, we found that pharmacological inhibition of 20S proteasomes stimulated NFAT transactivation in both mouse hearts and cultured adult mouse cardiomyocytes. Proteasome inhibition stimulated NFAT nuclear translocation in a calcineurin-dependent manner and led to a maladaptive cell shape change in cultured neonatal rat ventricular myocytes. Proteasome inhibition facilitated left ventricular dilatation and functional decompensation and increased fatality in mice with aortic constriction while causing cardiac hypertrophy in the sham surgery group. It was further revealed that both calcineurin protein levels and NFAT transactivation were markedly increased in the mouse hearts with desmin-related cardiomyopathy and severe PFI. Expression of an aggregation-prone mutant desmin also directly increased calcineurin protein levels in cultured cardiomyocytes.ConclusionsThe calcineurin-NFAT pathway in the heart can be activated by proteasome inhibition and is activated in the heart of a mouse model of desmin-related cardiomyopathy that is characterized by severe PFI. The interplay between PFI and the calcineurin-NFAT pathway may contribute to the pathological remodelling of cardiomyocytes characteristic of congestive heart failure.

KW - Calcineurin

KW - Cardiac remodelling

KW - Desmin-related cardiomyopathy

KW - Nuclear factors of activated T-cells

KW - Proteasome

UR - http://www.scopus.com/inward/record.url?scp=77957356238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957356238&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvq217

DO - 10.1093/cvr/cvq217

M3 - Article

VL - 88

SP - 424

EP - 433

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 3

ER -